Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis

gan Purohit, Vivek, Riley, Steve, Tan, Huaming, Ports, William C.
Cyhoeddwyd yn J Clin Pharmacol (2020)

Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data

gan Armstrong, April W., Koning, J. Will, Rowse, Simon, Tan, Huaming, Mamolo, Carla, Kaur, Mandeep
Cyhoeddwyd yn Dermatol Ther (Heidelb) (2016)

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis

gan Xin, Xiaoyan, Zeng, Xianqin, Gu, Huajian, Li, Min, Tan, Huaming, Jin, Zhishan, Hua, Teng, Shi, Rui, Wang, Hongbo
Cyhoeddwyd yn Sci Rep (2016)

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis

gan Valenzuela, Fernando, Papp, Kim A, Pariser, David, Tyring, Stephen K, Wolk, Robert, Buonanno, Marjorie, Wang, Jeff, Tan, Huaming, Valdez, Hernan
Cyhoeddwyd yn BMC Dermatol (2015)

Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposu...

gan Burmester, Gerd R, Nash, Peter, Sands, Bruce E, Papp, Kim, Stockert, Lori, Jones, Thomas V, Tan, Huaming, Madsen, Ann, Valdez, Hernan, Cohen, Stanley B
Cyhoeddwyd yn RMD Open (2021)

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

gan Callender, Valerie D., Alexis, Andrew F., Stein Gold, Linda F., Lebwohl, Mark G., Paller, Amy S., Desai, Seemal R., Tan, Huaming, Ports, William C., Zielinski, Michael A., Tallman, Anna M.
Cyhoeddwyd yn Am J Clin Dermatol (2019)